# Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

> **NCT02592473** · NA · UNKNOWN · sponsor: **University of Virginia** · enrollment: 50 (estimated)

## Conditions studied

- Prostatic Hyperplasia
- Benign Prostatic Hyperplasia (BPH)
- Prostatism
- Lower Urinary Tract Symptoms (LUTS)
- Prostatic Hypertrophy
- Hyperplasia
- Male Urogenital Diseases
- Genital Diseases, Male

## Interventions

- **DEVICE:** Embozene Microspheres

## Key facts

- **NCT ID:** NCT02592473
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2021-11
- **Final completion:** 2021-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02592473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02592473, "Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02592473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*